CSHL Double Helix Medals - Meet Mikala and Mike

TL;DR

Scientists share breakthroughs in cancer and autism research at Cold Spring Harbor Laboratory.

Transcript

(pleasant instrumental music) (applause) - And the road to discovery continues. We know it's not possible for all of you in this room to make it out to Long Island to the lab, so we thought we'd bring a little bit of the magic of the lab here to this ballroom. And with me on stage are two of the young scientists who represent a host of unbelievable... Read More

Key Insights

• Mikala Egeblad's research focuses on the microenvironment of cancer tumors and the role of cells in cancer growth, utilizing advanced microscopy techniques.
• Michael Ronemus studies the genetic components of autism, identifying over 100 gene mutations linked to the disorder, aiming for early intervention strategies.
• Both scientists have personal motivations driving their research; Egeblad's family history with cancer and Ronemus's child diagnosed with autism.
• Egeblad's work aims to disrupt the signals that turn immune cells into cancer-supporting cells, potentially improving existing cancer therapies.
• Ronemus's research hopes to refine genetic testing for autism, enabling early diagnosis and personalized treatment plans for affected children.
• The research at Cold Spring Harbor Laboratory is collaborative, with techniques developed for cancer research aiding autism studies and vice versa.
• The lab's supportive environment allows researchers to pivot their focus, as demonstrated by Ronemus's shift from plant genetics to autism research.
• Both scientists emphasize the importance of understanding the broader cellular environment in disease progression, not just the primary disease cells.

Questions & Answers

Q: What is Mikala Egeblad's research focus?

Mikala Egeblad focuses on the microenvironment of cancer tumors, particularly how cells foster cancer growth. Her work utilizes advanced microscopy to observe interactions between cancer cells and immune cells. She aims to identify and disrupt signals that turn immune cells into cancer-supporting cells, potentially enhancing existing cancer therapies.

Q: How did Michael Ronemus become involved in autism research?

Michael Ronemus shifted to autism research after his oldest child was diagnosed with an autism spectrum disorder. Initially working in plant genetics, he was motivated to apply his skills to understand autism better. His work involves identifying genetic mutations linked to autism, aiming to improve early diagnosis and intervention strategies.

Q: What personal experiences influence Mikala Egeblad's research?

Mikala Egeblad's research is influenced by her family's extensive history with cancer. This personal connection adds urgency to her work, driving her to understand the tumor microenvironment better and identify ways to disrupt cancer-supporting immune cells, ultimately aiming to improve cancer treatment outcomes.

Q: How does Michael Ronemus's research benefit from the Cold Spring Harbor Laboratory environment?

The collaborative environment at Cold Spring Harbor Laboratory allows Michael Ronemus to leverage genetic techniques developed for cancer research in his autism studies. This synergy enables more precise identification of autism-related mutations, contributing to advancements in understanding and potentially treating autism.

Q: What are the potential outcomes of Michael Ronemus's research on autism?

Michael Ronemus's research aims to refine genetic testing for autism, allowing for earlier diagnosis and personalized treatment plans. By identifying specific gene mutations linked to autism, his work could lead to targeted interventions during critical developmental windows, potentially improving outcomes for children with autism.

Q: What techniques does Mikala Egeblad use in her cancer research?

Mikala Egeblad uses advanced microscopy techniques to study the interactions between cancer cells and immune cells within the tumor microenvironment. Her innovative approach involves observing live tumors in mice, aiming to identify and disrupt signals that turn immune cells into cancer-supporting cells, enhancing the effectiveness of cancer therapies.

Q: How does the research at Cold Spring Harbor Laboratory impact cancer and autism studies?

Research at Cold Spring Harbor Laboratory is highly collaborative, with techniques developed for one field often benefiting another. For example, genetic techniques initially used in cancer research are now aiding autism studies, allowing for more precise identification of mutations. This cross-disciplinary approach accelerates advancements in both cancer and autism research.

Q: What is the significance of the Era of Hope Scholar award for Mikala Egeblad?

The Era of Hope Scholar award, given to Mikala Egeblad by the Defense Department's breast cancer research program, recognizes her innovative work in cancer research. This prestigious award highlights her contributions to understanding the tumor microenvironment and her efforts to disrupt cancer-supporting immune cells, aiming to improve cancer treatment outcomes.

Summary & Key Takeaways

• Mikala Egeblad and Michael Ronemus, researchers at Cold Spring Harbor Laboratory, discuss their groundbreaking work in cancer and autism. Egeblad's research focuses on the tumor microenvironment, while Ronemus studies genetic mutations in autism, both aiming for early intervention and improved treatments.

• Egeblad's personal connection to cancer through her family history drives her research to disrupt cancer-supporting immune cells. Ronemus, motivated by his child's autism diagnosis, aims to refine genetic testing for autism, facilitating early diagnosis and personalized treatment.

• The collaborative environment at Cold Spring Harbor Laboratory enables researchers to leverage techniques across different fields. This synergy enhances the precision of genetic studies in both cancer and autism, contributing to significant advancements in understanding and treating these conditions.